The latest biotech news

News and Trends 28 Apr 2015

Will 2015 be the year of biosimilars?

The Biosimilar drug field is growing fast despite the tight regulatory, business and financial challenges it faces. The industry is forecasted to be worth up to €23Bn by 2020. To explore the market opportunities for biosimilars, it is necessary to be aware of all the latest news and to stand at the forefront of the current landscape […]

April 28, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 27 Apr 2015

Ynsect: what’s behind this Yellow Biotech champion?

How do you manage a planet with a growing population with increasing consumption needs when you only have a limited amount of ressources available? Everybody knows it’s a never-ending debate, but some companies are grabbing their chance to change the world. Ynsect is one of the many firms trying to do so, and could be a future champion of the Yellow Biotech […]

April 27, 2015 - 5 minutesmins - By Joachim Eeckhout

News and Trends 25 Apr 2015

Desktop Genetics launches a new Gene Editing Platform

Desktop Genetics has just launched the DeskGen Platform for gene editing. It combines elements of the Company’s earlier tools, and allows researchers to design genome editing vectors and cloning strategies optimized to their own laboratories and experimental needs. The DeskGen platform gives life scientists the power to expertly design optimized genome editing experiments in any cell […]

April 25, 2015 - 2 minutesmins - By Julie Lellouche

News and Trends 24 Apr 2015

Novo Nordisk Takes on One of the World’s Biggest Markets: Obesity

Novo Nordisk, the Danish global healthcare company, received the all clear a few month ago from the US, EU and Canada to launch and sell a new treatment for Weight Management, Saxenda. The company announced the launch of Saxenda in the US, who present the treatment as an adjunct to a reduced-calorie diet and increased physical activity for chronic […]

April 24, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 24 Apr 2015

Interview with Dr. Andrei Popov, CEO at Ecrins Therapeutics

Dr. Andrei Popov, CEO at Ecrins Therapeutics Photo credit: Ecrins Therapeutics Laureate of the 2002 INSERM program “Avenir”, Dr. Andrei Popov launched a research project with a focus on the mechanisms of cell division and bioactive small molecules, both fields relevant to oncology (INSERM and Joseph Fourier University in Grenoble). The discovery of several drug […]

April 24, 2015 - 5 minutesmins - By Marie Godar

News and Trends 23 Apr 2015

Are personalized treatments for lung cancer underutilized?

Results from a new global survey of lung cancer oncologists have shown that, despite 81% of newly diagnosed advanced non-small cell lung cancer (NSCLC) patients being tested for Epidermal Growth Factor Receptor mutations (EGFR), a significant number of those tested were not receiving personalized treatments for their cancer type and mutation subtype. The survey, with […]

April 23, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 23 Apr 2015

Lab equipment (finally) affordable?

Whether you are an industry giant, university laboratory or startup company, there is no way around it! Obviously your equipment budget represents a necessity… Your wallet, however, suffers the most from these expensive supplies. Imagine being able to buy good and reliable supplies at prices well below market standards. Well, this dream has now become […]

April 23, 2015 - 2 minutesmins - By Alexandre Lowrey

News and Trends 22 Apr 2015

Vaccines against Parasites, on the Horizon with XstalBio

XstalBio has commenced work on an €9.3M EU Funded Horizon 2020 project to develop vaccines that protect cattle, sheep and poultry, against infection by parasites. The 4 year “PARAGONE” collaboration involves 17 partners from Europe, Uruguay and China and will aim to move several candidate vaccines from the laboratory into practical field trials. XstalBio, as […]

April 22, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 22 Apr 2015

OncoBEAM blood test arrives to Europe

Sysmex Inostics have signed an exclusive distributor agreement with IndivuTest, and its parent company Indivumed, a cancer research company focused on the development of individualized cancer diagnostics and therapies. This collaboration will offer Sysmex’s OncoBEAM services throughout Germany, Austria and Switzerland. IndivuTest will be responsible for commercial and sample logistics, with all testing being performed […]

April 22, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 22 Apr 2015

Synthetic sea anemone’s peptide to cure Autoimmune Diseases

Kineta and researchers from the University of Groningen, Netherlands, announced new data from a study that showed dalazatide (formerly ShK-186) is effective in immunomodulating the cells causing inflammation and damage of small blood vessels in various organs in samples from patients with Granulomatosis with Polyangiitis (GPA). The data were presented at the 17th International ANCA […]

April 22, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 22 Apr 2015

Erytech Strengthens its Intellectual Property Position in the US

Erytech strengthed its intellectual property portfolio in the United States with the granting of a new patent and the further extension of the patent term of its core process patent. The French biopharmaceutical company develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical needs. The patent entitled “Medicament for […]

April 22, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 22 Apr 2015

[Interview] Smartbone, using bioengineering to repair your bones!

Orthobiology is a field of biomedical technology, which develops new devices and products for skeletal regenerative medicine. IBI sa (Industrie Biomediche Insubri sa) is a Swiss-based company excelling in this field. I met Giuseppe Perale, co-founder and President of the company, who not only gave me the big picture on this field, but also on […]

April 22, 2015 - 5 minutesmins - By Joachim Eeckhout

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Will 2015 be the year of biosimilars?

Ynsect: what’s behind this Yellow Biotech champion?

Desktop Genetics launches a new Gene Editing Platform

Novo Nordisk Takes on One of the World’s Biggest Markets: Obesity

Interview with Dr. Andrei Popov, CEO at Ecrins Therapeutics

Are personalized treatments for lung cancer underutilized?

Lab equipment (finally) affordable?

Vaccines against Parasites, on the Horizon with XstalBio

OncoBEAM blood test arrives to Europe

Synthetic sea anemone’s peptide to cure Autoimmune Diseases

Erytech Strengthens its Intellectual Property Position in the US

[Interview] Smartbone, using bioengineering to repair your bones!

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!